Hot Products

ar-Curcumene
Catalog No: CFN89251

ar-Curcumene has antiinflammatory activity, it could be used as antiinflammatory drugs in respiratory infections. ar-Curcumene is effective as oviposition deterrents against Anopheles stephensi, Aedes aegypti, and Culex quinquefasciatus, it can be considered for the development of novel and effective mosquito larvicides.

Ardisiacrispin A
Catalog No: CFN90177

Ardisiacrispin A has cytotoxic activity toward HepG2 cancer cell with the GI(50) value of 1.56μM, it could inhibit the proliferation of Bel-7402 cells by inducing apoptosis and disassembling microtubule.Ardisiacrispin(A+B) exhibit prominent abilities to inhibit the proliferation of HL-60 cells by blocking the cell cycle at S phase and inducing apoptosis.

Ardisiacrispin B
Catalog No: CFN91120

Ardisiacrispin B displays cytotoxic effects in multi-factorial drug resistant cancer cells via ferroptotic and apoptotic cell death.

Ardisicrenoside A
Catalog No: CFN91122

Reference standards.

Arecaidine
Catalog No: CFN93320

Arecaidine has tumorgenicity.

Arecaidine hydrochloride
Catalog No: CFN93357

Arecaidine hydrochloride may have carcinogenesis.

Arecoline hydrobromide
Catalog No: CFN90799

Arecoline hydrobromide is formerly used as a cholinergic agent, it is a hypotensive agent. Arecoline hydrobromide is purgative, vermifuge and taenifuge agents in veterinary medicine. It induces rat hepatic CYP2 B by promoting nuclear translocation of CAR, the regulation of it on rat hepatic CYP2 B largely involve transcriptional activation of the gene,partially involve the post-translational modification of CYP2 B protein.

Arenobufagin
Catalog No: CFN98578

Arenobufagin is a potent Na + /K + pump inhibitor, and is also a specific inhibitor of VEGF-mediated angiogenesis. Arenobufagin has antineoplastic effect that involves cross talk between apoptosis and autophagy via inhibition of the PI3K/Akt/mTOR pathway.

Arganine B
Catalog No: CFN95281

Arglabin
Catalog No: CFN89201

Arglabin has antiatherogenic effects, it may represent a new promising compound to treat inflammation and type 2 diabetes mellitus development, it can attenuate inflammation, protect pancreatic β-cells from apoptosis, and prevent Type 2 diabetes mellitus development in ApoE2Ki mice on a chronic high-fat diet. Arglabin shows promising antitumor activity against different tumor cell lines, Arglabin-DMA inhibits cell proliferation of a variety of tumor types with IC(90)s in the range of 0.85 to 5.0 microg/ml.